SCHEMBL953972

SCHEMBL953972

Nc1ccc(CC2=NCCN2)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.82
HTR1D P28221 6/20 0.69
TAAR1 Q96RJ0 7/20 0.68
ADRA2A P08913 3/20 0.68
ADRA2B P18089 3/20 0.68
ADRA2C P18825 3/20 0.68
ADRA1A P35348 3/20 0.68
CYP2D6 P10635 3/20 0.68
ADRA1D P25100 2/20 0.68
ADRA1B P35368 2/20 0.68
TSHR P16473 2/20 0.68
LMNA P02545 2/20 0.68
CYP1A2 P05177 1/20 0.68
HTR1B P28222 4/20 0.68
NFKB1 P19838 1/20 0.57
PTGIR P43119 1/20 0.54
NISCH Q9Y2I1 2/20 0.47
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4036373 0.89 RAD52 (0.68) RAD52HTR1DTAAR1ADRA2AADRA2B
SCHEMBL4629569 0.84 RAD52 (0.61) RAD52HTR1DTAAR1ADRA2AADRA2B
SCHEMBL4032937 0.84 MAOA (0.69) RAD52HTR1DTAAR1ADRA2AADRA2B
Hydrochloric Acid SCHEMBL4711895 0.84 MAOA (0.69) RAD52HTR1DTAAR1ADRA2AADRA2B
SCHEMBL4037274 0.83 HTR1D (0.71) RAD52HTR1DTAAR1ADRA2AADRA2B
Hydrochloric Acid SCHEMBL4711894 0.82 MAOA (0.67) RAD52HTR1DTAAR1ADRA2AADRA2B
SCHEMBL9393147 0.81 HTR1D (0.69) RAD52HTR1DTAAR1ADRA2AADRA2B
SCHEMBL2869241 0.81 HTR1D (0.69) RAD52HTR1DTAAR1ADRA2AADRA2B
Tolazoline SCHEMBL34961 0.81 TAAR1 (1.00) RAD52HTR1DTAAR1ADRA2AADRA2B
SCHEMBL10846015 0.81 TAAR1 (0.72) RAD52HTR1DTAAR1ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1635821-B1 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL)AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARM INC (US) 2009-07-08 EP claimed
CN-101374516-A Use of substituted 2-imidazole of imidazoline derivatives HOFFMANN LA ROCHE (CH) 2009-02-25 CN claimed
US-20070197621-A1 Method for the treatment of CNS disorders with substituted 2-imidazoles or imidazole derivatives F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2007-08-23 US claimed
US-20070123531-A1 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases ELAN PHARMACEUTICALS, INC. 2007-05-31 US claimed
EP-1635821-A2 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL)AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES Elan Pharmaceuticals, Inc. (US) 2006-03-22 EP claimed
US-20050032868-A1 Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists ELAN PHARMACEUTICALS, INC. 2005-02-10 US claimed
WO-2004099155-A2 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL) AMIDE DERIVATES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMATORY DISEASES ELAN PHARMACEUTICALS, INC. (US) 2004-11-18 WO claimed
US-20250387373-A1 SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS OHIO STATE INNOVATION FOUNDATION (US) 2025-12-25 US disclosed
US-12390449-B2 Substituted 2-aminobenzimidazoles analogs as antibiofilm agents OHIO STATE INNOVATION FOUNDATION (US) 2025-08-19 US disclosed
EP-4590938-A1 INTER-TURBINE CASING FOR A TURBINE ENGINE, TURBINE ENGINE ASSEMBLY, TURBINE ENGINE AND METHOD FOR POSITIONING A SPLITTER VANE WITHIN AN INTER-TURBINE CASING SAFRAN AIRCRAFT ENGINES (FR) 2025-07-30 EP disclosed
CN-119243160-A Novel alkaline copper CMP polishing solution and preparation method thereof 河北工业大学 2025-01-03 CN disclosed
CN-119243160-A Novel alkaline copper CMP polishing solution and preparation method thereof 河北工业大学 2025-01-03 CN disclosed
US-20240156788-A1 SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS NORTH CAROLINA STATE UNIVERSITY 2024-05-16 US disclosed
US-20070123531-A1 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases ELAN PHARMACEUTICALS, INC. 2007-05-31 US disclosed
EP-1635821-A2 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL)AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES Elan Pharmaceuticals, Inc. (US) 2006-03-22 EP disclosed
US-20050032868-A1 Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists ELAN PHARMACEUTICALS, INC. 2005-02-10 US disclosed
WO-2004099155-A2 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL) AMIDE DERIVATES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMATORY DISEASES ELAN PHARMACEUTICALS, INC. (US) 2004-11-18 WO disclosed
EP-0331507-B1 POLYVINYL CHLORIDE PLASTISOL COMPOSITION ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1993-05-19 EP disclosed
US-4977201-A Blended with modified epoxy resin, blocked isocyanate, latent curing for resin as tackifier, automobile undercoatings ASAHI DENKA KOGYO K.K. (JP) 1990-12-11 US disclosed
EP-0331507-A1 Polyvinyl chloride plastisol composition ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1989-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123531-A1 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases BDKRB1, BDKRB2, LTB4R RAD52 3545/4885HTR1D 347/4885TAAR1 109/4885
US-12390449-B2 Substituted 2-aminobenzimidazoles analogs as antibiofilm agents ITGB3, ITGB2, ITGAM RAD52 4312/4885HTR1D 2458/4885TAAR1 2718/4885
US-20250387373-A1 SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS ITGB3, CFTR, Q6ZSR9 RAD52 4361/4885HTR1D 109/4885TAAR1 1224/4885
US-20050032868-A1 Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists BDKRB1, BDKRB2, BRS3 RAD52 2927/4885HTR1D 231/4885TAAR1 351/4885
US-20070197621-A1 Method for the treatment of CNS disorders with substituted 2-imidazoles or imidazole derivatives GPR119, PER2, MTNR1B RAD52 4584/4885HTR1D 28/4885TAAR1 117/4885
US-20240156788-A1 SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS ITGB3, ITGB2, ITGAM RAD52 4312/4885HTR1D 2458/4885TAAR1 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.